VAERS reports by lot

Pfizer COVID-19 lot EN8727: VAERS reports

29 VAERS reports list lot EN8727 as a Pfizer COVID-19 vaccine, received between 2021-03-18 and 2023-11-03. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
29
Reports
10%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)4236%
Neurological1513%
Cardiac / Cardiovascular1412%
Gastrointestinal1210%
Injection-site / Local reaction76%
Respiratory65%
Allergic / Anaphylactic54%
Musculoskeletal43%
Dermatological (non-injection-site)43%
Reproductive / Menstrual43%
Psychiatric / Neuropsychiatric22%
Thrombotic / Hematological11%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania6
Texas5
New York4
New Jersey2
Tennessee2
Oklahoma1
Kansas1
Connecticut1
Colorado1
Maryland1
Alabama1
Virginia1

Reports by month received

2021-035
2021-046
2021-052
2021-062
2021-075
2021-092
2021-112
2022-011
2022-121
2023-011
2023-091
2023-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.